Systemic alteration of cell-surface and secreted glycoprotein expression in malignant breast cancer cell lines

Glycobiology

Volumn 23, Issue 11, 2013, Pages 1240-1249

  Timpe, Leslie C ^a   Yen, Roger ^a   Haste, Nicole V ^a   Litsakos Cheung, Christina ^a   Yen, Ten Yang ^a   Macher, Bruce A ^a  

^a SAN FRANCISCO STATE UNIVERSITY   (United States)

Author keywords

Breast cancer; Glycoproteins; Glycosylation sites; Mass spectrometry; Proteomics

Indexed keywords

5' NUCLEOTIDASE; ACID CERAMIDASE; ALKALINE PHOSPHATASE; ALPHA3 INTEGRIN; APOLIPOPROTEIN D; ASPARAGINE; ASPARTIC ACID; BASAL CELL ADHESION MOLECULE; BETA1 INTEGRIN; CARBONATE DEHYDRATASE XII; CATHEPSIN D; CD147 ANTIGEN; CD151 ANTIGEN; CD63 ANTIGEN; CELL ADHESION MOLECULE; CELL SURFACE PROTEIN; DIPEPTIDYL PEPTIDASE I; FIBRONECTIN; GLUCAN 1,4 ALPHA GLUCOSIDASE; GLYCOPEPTIDASE; GLYCOPEPTIDE; GLYCOPROTEIN; HERMES ANTIGEN; INTEGRIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; MESSENGER RNA; MICROSOMAL AMINOPEPTIDASE; NECTIN 1; NERVE CELL ADHESION MOLECULE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BASEMENT MEMBRANE; BREAST ADENOCARCINOMA; BREAST CANCER; BREAST CARCINOMA; BREAST EPITHELIUM; BREAST TUMOR; CANCER CELL CULTURE; CELL CULTURE; CELL FRACTIONATION; CELL SURFACE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FIBROCYSTIC BREAST DISEASE; GENE DOSAGE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LIQUID CHROMATOGRAPHY; MALIGNANT NEOPLASTIC DISEASE; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN ISOLATION; PROTEIN SECRETION; PROTEIN STRUCTURE; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING;

BREAST CANCER; GLYCOPROTEINS; GLYCOSYLATION SITES; MASS SPECTROMETRY; PROTEOMICS;

AMINO ACID SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; CONSENSUS SEQUENCE; FEMALE; GENE DOSAGE; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; MEMBRANE PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOME; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 84886074678     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwt060     Document Type: Article

References (30)

1. Bateman NW, Sun M, Hood BL, Flint MS, Conrads TP. 2010. Defining central themes in breast cancer biology by differential proteomics: Conserved regulation of cell spreading and focal adhesion kinase. J Proteome Res. 9 (10):5311-5324.
2. Boersema PJ, Geiger T, Wisniewski Mann M. 2013. Quantification of the N-glycosylated secretome by super-SILAC during breast cancer progression and in human blood samples. Mol Cell Proteomics. 12:158-171.
3. Drake PM, Schilling B, Niles RK, Prakobphol A, Li B, Jung K, Cho W, Braten M, Inerowicz HD, Williams K, et al. 2012. Lectin chromatography/mass spectrometry discovery workflow identifies putative biomarkers of aggressive breast cancers. J Proteome Res. 11:2508-2520.
4. Evdokimova V, Tognon C, Ng T, Ruzanov P, Melnyk N, Fink D, Sorokin A, Ovchinnikov LP, Davicioni TJ, Sorensen PHB. 2009. Translational activation of Snail and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition. Cancer Cell. 15:402-415.
5. Forozan F, Veldman R, Ammerman CA, Parsa NZ, Kallioneimi A, Kallioneimi O-P, Ethier SP. 1999. Molecular cytogenetic analysis of 11 new breast cancer cell lines. Br J Cancer. 81(8):1328-1334.
6. Geiger T, Cox J, Mann M. 2010. Proteomic changes resulting from gene copy number variations in cancer cells. PLoS Genet. 6(9):e1001090.
7. Geiger T, Madden SF, Gallagher WM, Cox J, Mann M. 2012. Proteomic portrait of human breast cancer progression identifies novel prognostic markers. Cancer Res. 72:2428-2439.
8. Heiser LM, Sadanandam A, Kuo W-L, Benz SC, Goldstein TC, Ng S, Gibb WJ, Wang NJ, Ziyada S, Tong F, et al. 2012. Subtype and pathway specific responses to anticancer compounds in breast cancer. Proc Natl Acad Sci USA. 2012:2724-2729.
9. Hua S, Kittler R, White KP. 2009. Genomic antagonism between retinoic acid and estrogen signaling in breast cancer. Cell. 137:1259-1271.
10. Kulasingam V, Diamandis EP. 2007. Proteomics analysis of conditioned media from three breast cancer cell lines: A mine for biomarkers and therapeutic targets. Mol Cell Proteomics. 6(11):1997-2011. (Pubitemid 350201873)
11. Leth-Larsen R, Lund R, Hansen HV, Laenkholm A-V, Tarin D, Jensen ON, Ditzel HJ. 2009. Metastasis-related plasma membrane proteins of human breast cancer cells identified by comparative quantitative mass spectrometry. Mol Cell Proteomics. 8:1436-1449.
12. Lu P, Takai K, Weaver VM, Werb Z. 2011. Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harbor Perspect Biol. 3(12). doi:pii: a005058.10.1101/cshperspect.a005058
13. Ludwig JA, Weinstein JN. 2005. Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer. 5:845-856. (Pubitemid 41746029)
14. Martin TA, Jiang WG. 2009. Loss of tight junction barrier function and its role in cancer metastasis. Biochim Biophys Acta. 1788(4):872-891.
15. McDonald CA, Yang JY, Marathe V, Yen T-Y, Macher BA. 2009. Combining results from lectin affinity chromatography and glycoproteins capture approaches substantially improves the coverage of the glycoproteome. Mol Cell Proteomics. 8:287-301.
16. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, et al. 2006. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 10(6):515-527. (Pubitemid 44854747)
17. Old WM, Meyer-Arendt K, Aveline-Wolf L, Pierce KG, Mendoza A, Sevinsky JR, Resing KA, Ahn NG. 2005. Comparison of label-free methods for quantifying human proteins by shotgun proteomics. Mol Cell Proteomics. 4(10):1487-1502. (Pubitemid 41555475)
18. Paredes J, Figueiredo J, Albergaria A, Oliveira P, Carvalho J, Ribeiro AS, Caldeira J, Costa AM, Simões-Correia J, Oliveira MJ, et al. 2012. Epithelial E- and P-cadherins: Role and clinical significance in cancer. Biochim Biophys Acta. 1826(2):297-311.
19. Spiro RG. 2002. Protein glycosylation: Nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. Glycobiology. 12(4):43R-56R. (Pubitemid 34760066)
20. Thaysen-Andersen M, Packer N. 2012. Site-specific glycoproteomics confirms that protein structure dictates formation of N-glycan type, core fucosylation and branching. Glycobiology. 22(11):1440-1452.
21. Thiery JP. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2:442-454.
22. Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME. 2009. Essentials of Glycobiology, 2nd ed., www.ncbi.nlm. nih.gov/books/NBK1908/. (14 August 2013, date last accessed).
23. Weinberg RA. 2007. The Biology of Cancer. New York, NY: Garland Science.
24. Whelan SA, Lu M, He J, Yan W, Saxton RE, Faull KF, Whitelegge JP, Chang HR. 2009. Mass spectrometry (LC-MS/MS) site-mapping of N-glycosylated membrane proteins for breast cancer biomarkers. J Proteome Res. 8 (8):4151-4160.
25. Wollscheid B, Bausch-Fluck D, Henderson C, O'Brien R, Bibel M, Schiess R, Aebersold R, Watts JD. 2009. Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins. Nat Biotechnol. 27 (4):378-386.
26. Yen T-V, Macher BA, McDonald CA, Alleyne-Chin C, Timpe LC. 2012. Glycoprotein profiles of human breast cells demonstrate a clear clustering of normal/benign versus malignant cell lines and basal versus luminal cell lines. J Proteome Res. 11:656-667.
27. Zhang H, Li XJ, Martin DB, Aebersold R. 2003. Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat Biotechnol. 21:660-666. (Pubitemid 36638093)
28. Zhang B, Ver Berkmoes NC, Langston MA, Uberbacher E, Hettich RL, Samatova NF. 2006. Detecting differential and correlated protein expression in label-free shotgun proteomics. J Proteome Res. 5:2909-2918. (Pubitemid 44749209)
29. Zhu W, Smith JW, Huang C-M. 2010. Mass spectrometry-based label-free quantitative proteomics. J Biomed Biotech. 2010:6 pages, Article ID 840518, doi:10.1155/2010/840518.
30. Zielinska DF, Gnad F, Wisniewski JR, Mann M. 2010. Precision mapping of an in vivo N-glycoproteome reveals rigid topological and sequence constraints. Cell. 141:897-907.